Last Updated：2025/11/29
Pharmaceutical companies are investing more in orphan drugs to address rare genetic disorders that have been neglected for decades.
See correct answer
Pharmaceutical companies are investing more in orphan drugs to address rare genetic disorders that have been neglected for decades.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
